Atqah Abdulwahab

Atqah Abdulwahab MBBS

Senior Attending Physician
  • About Atqah

    Dr. Atqah is a senior attending pediatric pulmonologist at Sidra Medicine, an associate professor of pediatrics at Qatar Medical College, and an assistant professor of clinical pediatrics at Weill Cornell Medical College.

    She is the multidisciplinary pediatric aerodigestive clinic's director at Sidra Medicine and is in charge of the fellows and rotating residents' pediatric pulmonary educational activities.

    Dr. Atqah is credited with being the first pediatric pulmonologist to identify the CF gene in a cohort of Qatari cystic fibrosis patients and to discover a new type of Ehlers-Danlos like associated with arterial tortuously syndrome.

    Dr. Atqah established the first CF clinics, the CF microbiology laboratory, and the sweat chloride test in biochemistry at Hamad Medical Corporation. She also started MDT pediatric aerodigestive clinic at Sidra Medicine in January 2019.
    Dr. Atqah participated in numerous important international conferences, including the European Respiratory Society and the European Cystic Fibrosis Conferences, where he presented oral papers and numerous scientific posters. She reviewed several research articles for national and international scholarly journals of medicine.

    She authored more than 55 scientific publications that were published in local and peer-reviewed journals, with her core research interests in cystic fibrosis and asthma.


    Languages Spoken

    English, Arabic

    • MBBS
      Faculty of Medicine
      King Saud University
      Riyadh, Kingdom of Saudi Arabia
    • Assistant Professor in Clinical Pediatrics at Weill-Cornell Medical College in Qatar (WCMC-Q)
    Areas of Interest
    • Cystic Fibrosis
    • Asthma
    • Pediatric Aerodigestive
    • Bronchoscopy
    Medical Publications (Only 5 publications max from past 5 years)
    1. Use of Intravenous Pulse Steroids to Treat Allergic Bronchopulmonary Aspergillosis in a Non-Compliant Asthmatic Adolescent. Children PMID: 35204972
    2. First report of the cystic fibrosis transmembrane conductance regulator mutation in two Qatari patients with cystic fibrosis. Qatar Med J. 2021 Jul 26;2021(1):24. doi: 10.5339/qmj.2021.24.
    3. Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization. Cureus 13(6): e15948. doi:10.7759/cureus.2021
    4. Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation. Translational Medicine Communications, September 1, 2020
    5. Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions. Multidiscip Respir Med. 2019 Oct 1;14:29